Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 7021 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

Aruna BIO Establishes Stroke Advisory Board to Advance Lead Program, AB126 into the Clinic

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Aruna Bio

4DMT to Participate in Upcoming Investor Conferences

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: 4D Molecular Therapeutics, Inc.

Tome Biosciences Forms Science and Technology Advisory Committee

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Tome Biosciences

Elixirgen Therapeutics Presents Preclinical Data with Bobcat mRNATM Technology in Duchenne Muscular Dystrophy at the 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Elixirgen Therapeutics, Inc. | Elixirgen Scientific, Inc. | Elixirgen Scientific, Inc.

BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: BioCardia, Inc.

BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: BetterLife Pharma Inc.

MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker at the AAD Annual Meeting 2024

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: MoonLake Immunotherapeutics AG

atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: atai Life Sciences N.V.

Molecular Templates, Inc. Provides Interim Update

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Molecular Templates, Inc.

Invitation to Participate in STOP-PC Clinical Trial

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Oncotelic, Inc.

Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Ascendis Pharma A/S

Sofwave Medical to Present Pure Impact™ Strength and Muscle Toning Module’s First U.S. Industry Reveal at the 2024 American Academy of Dermatology (AAD) Annual Meeting

Read more ››

By: GlobeNewswire - 04 Mar 2024

GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: GRI Bio Inc.

Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Entera Bio Ltd.

Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Vaxcyte, Inc.

Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Fortress Biotech, Inc.

Intelligent Scopes Launches Helga AI-GEP™, an AI Platform for Gastroenterology with the Commencement of Validation of its AI Software Tool for Colon Cancer

Read more ››

By: GlobeNewswire - 04 Mar 2024

Alumis Announces Late-Breaker Psoriasis Phase 2 Data Presentation for Allosteric TYK2 Inhibitor ESK-001 at the American Academy of Dermatology 2024 Annual Meeting

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Alumis Inc.

Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information Updates

Read more ››

By: GlobeNewswire - 04 Mar 2024

Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference

Read more ››

By: GlobeNewswire - 04 Mar 2024

Related companies: Cassava Sciences, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑